By Brandon Salter Michael Brady Lynch Firm August 1, 2022 (Mass Tort News) - 2022 has been a momentous year for Multi-district Litigation, particularly in pharmaceutical MDLs such as Zantac, Valsartan, Elmiron, Taxotere, Nexium & Prilosec. It is expected that some of these cases will go to trial in the year 2023; however, the best is yet to come with new … [Read more...] about NEW MDL LITIGATION ON THE HORIZON